Sales & Marketing Sponsored 12 Questions with Kirsten Parr Kirsten Parr heads up CMC Connect, a division of IPG Health Medical Communications, and has over 25 years’ experience in the industry.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.